BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30865268)

  • 21. Atopic dermatitis induces the expansion of thymus-derived regulatory T cells exhibiting a Th2-like phenotype in mice.
    Moosbrugger-Martinz V; Tripp CH; Clausen BE; Schmuth M; Dubrac S
    J Cell Mol Med; 2016 May; 20(5):930-8. PubMed ID: 26931745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flow cytometric analyses of circulating regulatory T cells in patients with dermatitis herpetiformis and other immune mediated dermatoses.
    Quaglino P; Ponti R; Novelli M; Savoia P; Fava P; Papini M; Bernengo MG
    G Ital Dermatol Venereol; 2013 Apr; 148(2):197-201. PubMed ID: 23588145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic modulation of cutaneous autoimmunity by regulatory T cells.
    Loser K; Beissert S
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii20-2. PubMed ID: 16987825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on the immunological mechanism of action behind phototherapy.
    Tartar D; Bhutani T; Huynh M; Berger T; Koo J
    J Drugs Dermatol; 2014 May; 13(5):564-8. PubMed ID: 24809879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical electrophilic nitro-fatty acids potentiate cutaneous inflammation.
    Mathers AR; Carey CD; Killeen ME; Salvatore SR; Ferris LK; Freeman BA; Schopfer FJ; Falo LD
    Free Radic Biol Med; 2018 Feb; 115():31-42. PubMed ID: 29132974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical analysis of regulatory T cell markers FOXP3 and GITR on CD4+CD25+ T cells in normal skin and inflammatory dermatoses.
    de Boer OJ; van der Loos CM; Teeling P; van der Wal AC; Teunissen MB
    J Histochem Cytochem; 2007 Sep; 55(9):891-8. PubMed ID: 17478450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The gut mucosa as a site for induction of regulatory T-cells.
    Mizrahi M; Ilan Y
    Curr Pharm Des; 2009; 15(11):1191-202. PubMed ID: 19355960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulatory cells in the skin: Pathophysiologic role and potential targets for anti-inflammatory therapies.
    Uttarkar S; Brembilla NC; Boehncke WH
    J Allergy Clin Immunol; 2019 Apr; 143(4):1302-1310. PubMed ID: 30664891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part III: Polymorphisms of genes involved in Tregs' activation and function.
    Nedoszytko B; Sokołowska-Wojdyło M; Renke J; Lange M; Trzonkowski P; Sobjanek M; Szczerkowska-Dobosz A; Niedoszytko M; Górska A; Romantowski J; Skokowski J; Kalinowski L; Nowicki RJ
    Postepy Dermatol Alergol; 2017 Dec; 34(6):517-525. PubMed ID: 29422815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulatory T cells: banned cells for decades.
    Loser K; Beissert S
    J Invest Dermatol; 2012 Mar; 132(3 Pt 2):864-71. PubMed ID: 22158548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-cell inducer populations in cutaneous inflammation: a predominance of T helper-inducer lymphocytes (THi) in the infiltrate of inflammatory dermatoses.
    Markey AC; Allen MH; Pitzalis C; MacDonald DM
    Br J Dermatol; 1990 Mar; 122(3):325-32. PubMed ID: 1969745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered expression of regulatory molecules in the skin of psoriasis.
    Sabag AD; Dias-Polak D; Bejar J; Sheffer H; Bergman R; Vadasz Z
    Immunol Res; 2018 Dec; 66(6):649-654. PubMed ID: 30613859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory T cells in skin injury: At the crossroads of tolerance and tissue repair.
    Boothby IC; Cohen JN; Rosenblum MD
    Sci Immunol; 2020 May; 5(47):. PubMed ID: 32358172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of Regulatory T Cells Causes Phenotypic and Functional Switch in Murine Peritoneal Macrophages.
    Skuljec J; Jirmo AC; Habener A; Talbot SR; Pul R; Grychtol R; Aydin M; Kleinschnitz C; Happle C; Hansen G
    Front Immunol; 2018; 9():2458. PubMed ID: 30429849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-regulatory T cells.
    Andersen MH
    Semin Immunopathol; 2017 Apr; 39(3):317-326. PubMed ID: 27677755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation.
    Gombert M; Dieu-Nosjean MC; Winterberg F; Bünemann E; Kubitza RC; Da Cunha L; Haahtela A; Lehtimäki S; Müller A; Rieker J; Meller S; Pivarcsi A; Koreck A; Fridman WH; Zentgraf HW; Pavenstädt H; Amara A; Caux C; Kemeny L; Alenius H; Lauerma A; Ruzicka T; Zlotnik A; Homey B
    J Immunol; 2005 Apr; 174(8):5082-91. PubMed ID: 15814739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA signature of regulatory T cells in health and autoimmunity.
    Soltanzadeh-Yamchi M; Shahbazi M; Aslani S; Mohammadnia-Afrouzi M
    Biomed Pharmacother; 2018 Apr; 100():316-323. PubMed ID: 29453041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T cell-regulated neutrophilic inflammation in autoinflammatory diseases.
    Keller M; Spanou Z; Schaerli P; Britschgi M; Yawalkar N; Seitz M; Villiger PM; Pichler WJ
    J Immunol; 2005 Dec; 175(11):7678-86. PubMed ID: 16301678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dermal regulatory T cells display distinct migratory behavior that is modulated during adaptive and innate inflammation.
    Chow Z; Mueller SN; Deane JA; Hickey MJ
    J Immunol; 2013 Sep; 191(6):3049-56. PubMed ID: 23940277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions.
    de Boer OJ; van der Meer JJ; Teeling P; van der Loos CM; van der Wal AC
    PLoS One; 2007 Aug; 2(8):e779. PubMed ID: 17712427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.